Navigation Links
Berman Calls Obama's Mexico City Policy Reversal an Important Step in Women's Rights, Health Care
Date:1/23/2009

VAN NUYS, Calif., Jan. 23 /PRNewswire-USNewswire/ -- Congressman Howard L. Berman (D-CA), chairman of the House Foreign Affairs Committee, said today President Obama's executive order repealing the Mexico City Policy is an important step in protecting women's rights and in improving health care worldwide.

"The President's action rights a wrong-headed policy that for eight years has hindered people in developing countries from having access to the contraceptives necessary to prevent unintended pregnancies, abortions, and the transmission of sexually transmitted infections, including HIV/AIDS," Berman said.

Known popularly as the Global Gag Rule, the Mexico City Policy prohibited federal funding for non-governmental organizations that discuss, counsel on, or provide abortions in developing countries. Berman observed that "this policy - which would violate the constitutional right to freedom of speech if placed on U.S.-based non-governmental organizations - applied even if abortion-related services were funded only with non-U.S. funds, and even if abortion was legal in the country in which services were provided."

"Repeal of these restrictions was long overdue," Berman noted, "and the action President Obama has taken is a clear signal that he intends to change how America works with the international community in solving global problems."


'/>"/>
SOURCE House Committee on Foreign Affairs
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces
2. Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case
3. Hagens Berman Sobol Shapiro Announces Investigation Into Marketing of Vytorin and Zetia
4. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
5. Hagens Berman: Eleven Defendants Settle in Average Wholesale Price Litigation
6. Hagens Berman Sobol Shapiro: Nationwide Class Action Certified in Average Wholesale Price Litigation
7. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
8. Hagens Berman Sobol Shapiro: Attorneys Representing Consumers Prepare for $12 Billion RICO Trial Against McKesson for Alleged Drug Price Manipulation
9. Hagens Berman Sobol Shapiro: Class Action Filed Against Spectranetics
10. Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign
11. Hagens Berman Sobol Shapiro: McKesson Settles RICO Lawsuit for $350 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... Children and adolescents who enter the ... children in the general population. That’s because foster care is designed to protect ... While no fault of their own, youth who have experienced trauma often have ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... could substantially improve drug safety and minimize the cost of development. In this ... channel inhibition using cell lines and for cardiac toxicity using induced pluripotent stem ...
(Date:4/28/2017)... Abilene, Texas (PRWEB) , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... says, reveals which name the Creator responds to and which He does not. Yisrayl ... to believe which one is the true name, but he says with a little Scripture, ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... the Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates to ... ERP expert that specializes in long-term care, Brooke Grove now has the capability ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a ... he has leant his presence to an educational purpose as the host of the ... one being cancer. In a recent episode, the series focuses on thyroid cancer. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... 2017 The Mobile X-Ray product segment is the ... during the forecast period Mobile X-Ray segment is ... mobile X-Ray devices market, which is estimated to be valued ... a CAGR of 7% over the forecast period. Mobile X-Ray ... than US$ 100 Mn in 2017 over 2016. The segment,s ...
Breaking Medicine Technology: